A detailed history of Howard Capital Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Howard Capital Management Inc. holds 19,949 shares of BMY stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,949
Previous 13,533 47.41%
Holding current value
$1.19 Million
Previous $700,000 61.14%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$51.92 - $59.94 $333,118 - $384,575
6,416 Added 47.41%
19,949 $1.13 Million
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $536,718 - $700,332
13,533 New
13,533 $700,000
Q3 2020

Oct 07, 2020

SELL
$57.43 - $63.64 $497,975 - $551,822
-8,671 Closed
0 $0
Q2 2020

Jul 13, 2020

BUY
$54.82 - $64.09 $475,344 - $555,724
8,671 New
8,671 $522,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $127B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Howard Capital Management Inc. Portfolio

Follow Howard Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Howard Capital Management Inc. with notifications on news.